Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Myelodysplastic Syndromes 21Lymphoma, Non-Hodgkin 17Leukemia 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Hematologic Neoplasms 7Leukemia, Myeloid, Accelerated Phase 6Leukemia, Biphenotypic, Acute 6Congenital Abnormalities 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Multiple Myeloma 5Lymphoma, Large B-Cell, Diffuse 5Breast Neoplasms 5Neuroblastoma 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Graft vs Host Disease 4Burkitt Lymphoma 4Recurrence 3Neuroectodermal Tumors, Primitive, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

Dexamethasone 17Melphalan 14Bortezomib 10Calcium Dobesilate 8Filgrastim 6Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 5birtamimab 4dexamethasone acetate 3Whole-Body Irradiation 3Thalidomide 3Peripheral Blood Stem Cell Transplantation 3Lenalidomide 3fludarabine phosphate 2daratumumab 2Mycophenolic Acid 2Etoposide 2Doxycycline 2Darbepoetin alfa 2Cyclosporine 2Busulfan 2Blood Component Removal 2pomalidomide 1pegfilgrastim 1ixazomib 1isatuximab 1ferrous sulfate 1ferric gluconate 1dexamethasone 21-phosphate 1carfilzomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Immunoglobulin Light-chain Amyloidosis × Thiotepa × Clear all
NCT00536601 2021-04-22

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase NA Completed
174 enrolled 17 charts
CNSDermatologicGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Neuroblastoma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡